Risk factors for thrombocytopenia and analysis of time to platelet transfusion after azacitidine treatment

MLA

M, Yasuda, et al. “Risk Factors for Thrombocytopenia and Analysis of Time to Platelet Transfusion after Azacitidine Treatment.” Die Pharmazie, vol. 76, no. 9, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8673c8d8dcbf71645faae2a32505dbf6&authtype=sso&custid=ns315887.

APA

M, Y., T, T., T, O., H, W., S, I., T, M., K, N., M, M., K, T., S, A., S, K., H, T., & T, M. (2021). Risk factors for thrombocytopenia and analysis of time to platelet transfusion after azacitidine treatment. Die Pharmazie, 76(9).

Chicago

M, Yasuda, Tachi T, Osawa T, Watanabe H, Inoue S, Makino T, Nagaya K, et al. 2021. “Risk Factors for Thrombocytopenia and Analysis of Time to Platelet Transfusion after Azacitidine Treatment.” Die Pharmazie 76 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8673c8d8dcbf71645faae2a32505dbf6&authtype=sso&custid=ns315887.